EDF Health

Hiding its tracks: The black box of EPA’s new chemical reviews just got a whole lot blacker

By / Published: January 4, 2018

Richard Denison, Ph.D., is a Lead Senior Scientist.

[UPDATED 1-8-18:  See updates below]

We have been blogging about damaging changes being made to the Environmental Protection Agency’s (EPA) new chemicals review program for some time.  Despite the reforms made in 2016 under the Lautenberg Act that were intended to significantly strengthen new chemical reviews, Scott Pruitt’s EPA has been moving since August of last year to seriously weaken the program.

Late yesterday, EPA made a change to its new chemicals website that not only reverses changes made to implement the Lautenberg Act, but actually makes the site less transparent than it has been for decades.[pullquote]EPA’s intent is now quite clear:  to prevent the public from knowing when EPA’s professional staff flagged any concern in their initial review of a new chemical.[/pullquote]

The change makes clear that the agency is now planning to cover its tracks as it weakens new chemical reviews:  EPA will now hide from the public any information about whether its initial review of a new chemical raises any concerns or warrants a more extensive review.  Is this what Scott Pruitt meant when he said he intended to bring increased “transparency” to the review program – a term he used no fewer than five times in his August news release previewing changes he was making?   Read More »

Posted in Health policy, Industry influence, Regulation, TSCA reform / Tagged , | Comments are closed

Podcast: Hurricane Harvey’s Toxic Aftermath

By / Published: January 3, 2018

In late August 2017, Hurricane Harvey’s torrential rains brought unprecedented flooding to Houston and large portions of the southeast coast of Texas. The storm destroyed homes and businesses, prompted numerous rescues, and left Texans to piece their lives back together. Harvey also led to substantial releases of toxic chemicals into communities.

The Houston area is home to hundreds of chemical plants and refineries. While highly visible incidents, like the explosions at the Arkema chemical plant, dominated news coverage, toxic chemical releases from plants occurred throughout the region.

In this episode of our podcast, we spoke with EDF’s own Dr. Elena Craft, who helped spearhead efforts to monitor these releases in real-time. Elena talks about her experiences on the ground, the inadequacies of many chemical plant risk management plans, and what it all means moving forward.

 

Want to hear about other environmental health issues? Subscribe and listen on iTunes or Google Play, or check out Podbean to listen via desktop!

Posted in Climate change, Extreme weather / Tagged | Read 1 Response

Federal court of appeals gives EPA one year to update lead-based paint standards

By Tom Neltner, Senior Director, Safer Chemicals Initiative / Published: December 29, 2017

Tom Neltner, J.D., is Chemicals Policy Director

Update: On July 2, 2018, EPA issued the proposed rule after the court gave it a 90-day extension. The agency has one year – until July 1, 2019 – to issue a final rule. Blog clarified on timing.

This week, the federal Ninth Circuit Court of Appeals directed the Environmental Protection Agency (EPA) to update its regulations defining lead-based paint and how much lead in dust represents a hazard. The court gave EPA 90 days to issue a proposed rule and one year later to publish a final rule with an option to convince the court that it needs additional time. The court said the agency had unreasonably delayed action on a citizen’s petition submitted in 2009. The science showing the need for action has only become more compelling in the eight years since EPA acknowledged the shortcoming of its rules. Rather than drag out this litigation, the agency should move quickly to revise its lead-based paint hazard standards to better protect children’s health.

EPA set the dust-lead hazard standard in 2001 after determining that a child living in a home with those levels had only a 1 to 5% chance of having an elevated blood lead level (EBLL) as defined by the Centers for Disease Control and Prevention (CDC). The scientific evidence now shows that the risk is greater than previously estimated. In addition, CDC has tightened its definition of an EBLL. As a result, according to the American Academy of Pediatrics, the risk to a child of having an EBLL in a home that meets EPA’s current dust-lead hazard standard is more than 50%.

Read More »

Posted in Health policy, Lead, Regulation / Tagged , , , , , | Comments are closed

Dourson emails show he was paid by and worked closely with ACC when providing states “advice” on chemicals made by ACC members

By / Published: December 21, 2017

Richard Denison, Ph.D., is a Lead Senior Scientist.

[Use this link to see all of our posts on Dourson.]

I blogged last week about how a trove of emails recently released by the New York Times shines a light on the cozy relationship between Michael Dourson, who just withdrew his nomination to run the Environmental Protection Agency’s (EPA) toxics office, and the American Chemistry Council (ACC), the main chemical industry trade association.  [pullquote]Dourson email to ACC staffer: “We should talk while I am still able to do so directly. I am not sure what limitations I will have with outside groups.”[/pullquote]You might ask why I’m blogging again about these emails.  It’s because they provide a rare and fascinating inside look at how – and how closely – paid consultants, who often tout themselves to the public and state and federal agencies as independent and objective arbiters of sound science, work with industry.  In this post I’ll describe what the emails tell us about Dourson’s work with state governments – and point to a “Bcc” in one of those emails that raises a big red flag.   Read More »

Posted in Health policy, Industry influence, TSCA reform / Tagged , , | Read 1 Response

We are what we eat: New paper outlines how the regulatory gaps in the US threaten our health

By Sarah Vogel / Published: December 20, 2017

Sarah Vogel, Ph.D., is Vice-President for Health.

In a new paper published in PLoS Biology today, Maricel Maffini, Tom Neltner and I detail the regulatory gaps in how the US manages chemicals in food. We explore how failures in our current regulatory system put the public’s health at risk as exemplified in the case of perchlorate, a chemical allowed in food and a well-known endocrine disrupting compound. Perchlorate’s ability to disrupt normal functioning of the thyroid means that even low levels of exposure, especially in those with inadequate iodine intake, can adversely impact the developing brains of infants and children. It is not a chemical that should be in the food of pregnant women, infants and children. And yet it is, and the levels children consume have increased in recent years.

Read More »

Posted in FDA, Food, GRAS, Health science, Perchlorate, Public health / Tagged , , , , , | Comments are closed

Systematic slowdown: EPA indefinitely delays virtually all proposed actions to restrict chemicals under TSCA

By / Published: December 20, 2017

Richard Denison, Ph.D., is a Lead Senior Scientist.  My colleague Ryan O’Connell assisted in the research described in this post.

By the time the long-awaited reforms of the Toxic Substances Control Act (TSCA) passed in June of 2016, nearly all stakeholders had come to agree that we needed a stronger federal chemical safety system, one that gave EPA more authority and more resources to act.  Only through this could public confidence in the system begin to be restored – to the benefit of both business and public health.

That was then.  A scant 18 months later, the law is being implemented by an Administration hell-bent on rolling back existing or indefinitely delaying new health protections, even those called for by large bipartisan majorities in Congress.  And the chemical industry?  So much for the influence of its better angels who supported reform.  It’s now going for broke, grabbing what it can while it can.[pullquote]Virtually every proposed action that would impose restrictions or conditions on specific chemicals has been either moved to the “long-term action” attic or simply deleted altogether.[/pullquote]

Yesterday, the New York Times and The Intercept ran stories spotlighting EPA’s decision to back-burner proposed restrictions on high-risk uses of three highly toxic chemicals – trichloroethylene (TCE), methylene chloride (MC), and N-methylpyrrolidone (NMP) – relegating them to the bureaucratic dustbin of “long-term actions.”  Not coincidentally, the chemical industry has strongly opposed all of the proposed restrictions.

But those aren’t the only proposed actions on chemicals for which this EPA has applied the brakes.  An examination of EPA’s two most recent semi-annual “unified agendas” – that trumpeted by the President last week, and the preceding one issued this past April – reveals a much broader and more disturbing pattern:  Virtually every proposed action that would impose restrictions or conditions on specific chemicals has been either moved to the “long-term action” attic or simply deleted altogether.   Read More »

Posted in Health policy, Industry influence, Regulation, TSCA reform / Tagged , | Read 1 Response